The Spin Doctors at the FDA
NegativeU.S News

In a troubling turn of events, Dr. Makary and Dr. Prasad have been criticized for their roles in the controversial decision to halt a promising melanoma drug. This decision has significant implications for patients seeking effective treatments, raising questions about accountability in the FDA's approval process. The fallout from this situation could impact future drug approvals and the trust patients place in regulatory bodies.
— Curated by the World Pulse Now AI Editorial System





